KLF3 and exstrophy-epispadias complex: Although we found KLF3 is a late-stage-specific SMG in EEC, there was no significant association between KLF3 mutation status and survival for EEC patients, possibly reflecting tissue-specific differences in KLF3 association with outcome, and/or outcome differences between mutation and reduced expression of KLF3.